Economic Literature Review An economic literature search was first conducted on October 9, 2012, and a second search was conducted on June 3, 2013, to update the literature
Chloramphenicol and other drugs having bone marrow suppressant properties may cause a lack of therapeutic response to vitamin B12
This introductory dose allows your body to adjust to the medication before increasing to higher maintenance doses that may produce greater weight loss and metabolic benefits
Clinical trials, such as STEP 1, factored a decrease in body weight average of 14-15% from the onset prior to the initiation of treatment in overweight individuals over a 68-week period
In September 2023 the FDA placed BPC-157 in Category 2 of its 503A interim bulk-substances policy, citing immunogenicity and peptide-characterization concerns, effectively excluding it from the 503A compounding bulk-substances list
We emphasize that while this update will increase the emphasis on Safety of Care, the Overall Hospital Quality Star Rating is still intended to be a summary of overall quality, and other measure groups will still contribute meaningfully to a hospital's rating
